Menarini Asia-Pacific, a member of the world's largest Italian biopharmaceutical company, officially inaugurated the establishment of Menarini (China) Investment Co. Ltd. and the opening of its national headquarters on 29 October 2013 at the Wuhan National Bioindustry Base ("Wuhan Biolake") in Hubei Province, China.
Menarini Asia-Pacific (formerly known as the Invida Group) was originally formed in 2005 by a strategic partnership of Quintiles Inc., Temasek Holdings and the Zuellig Group.
In November 2011, Italy's largest pharmaceutical company, Menarini Group, acquired the Invida Group in a strategic move that leveraged each company's strengths and created synergies between the two organisations. To leverage a single, global unified brand, Invida was rebranded Menarini Asia-Pacific in December 2012.
Menarini Asia-Pacific carries with it the history, relationships and strong track record of its global partners.